The International Classification of Functioning, Disability and Health Core Set for deafblindness. Part I: a systematic review of outcome measures.


Journal

European journal of physical and rehabilitation medicine
ISSN: 1973-9095
Titre abrégé: Eur J Phys Rehabil Med
Pays: Italy
ID NLM: 101465662

Informations de publication

Date de publication:
Oct 2023
Historique:
medline: 14 11 2023
pubmed: 17 7 2023
entrez: 17 7 2023
Statut: ppublish

Résumé

The International Classification of Functioning, Disability, and Health (ICF), developed by the World Health Organization, is a classification framework that focuses on the health and functioning of people with disabilities. As part of an ICF Core Set development, four studies need to be conducted, one of which is a systematic review. This study presents part 1 of the systematic review that aims to describe the outcome measures identified in the literature related to functioning in individuals with deafblindness. The research team screened articles from eight scientific databases, three journals, and Google Scholar (March 2011 to September 2022). Articles were included if they studied individuals with deafblindness aged 18 and older. Studies that examined genetics or laboratory experiments involving animals were excluded. Data were extracted into a logbook with key descriptors such as study location and design, age of study population, and instruments/outcome measures used, which were further categorized into one of the following types: 1) standardized; 2) patient-reported measures, standardized (PT-S); 3) patient-reported measures, not standardized (PT-not S); 4) health professional, reported measures, standardized (HP-S); 5) Technical measures; 6) other measures (parent-reported standardized and laboratory measures). The review included 147 studies, of which most were conducted in Europe (47.6%) and North America (27.9%). Of the 314 identified outcome measures, 57 were Standardized, 59 were Patient Reported-Standardized (PT-S), 178 were patient reported non-standardized (PT-Not S) variables, 11 were health professional reported, standardized, five were technical, and four were classified as other measures. Most instruments measured functioning in daily activities and the mental health of individuals with deafblindness. Three deafblind-specific instruments were identified in this study, highlighting the need for more deafblind-specific instruments to be developed and utilized in research.

Identifiants

pubmed: 37458491
pii: S1973-9087.23.07890-5
doi: 10.23736/S1973-9087.23.07890-5
pmc: PMC10664768
doi:

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

615-627

Références

Assist Technol. 2022 Jul 4;34(4):383-391
pubmed: 33200974
Am J Public Health. 2004 May;94(5):823-9
pubmed: 15117707
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S454-66
pubmed: 22588766
Int J Audiol. 2014 Feb;53(2):65-76
pubmed: 24313738
PLoS One. 2021 Dec 14;16(12):e0261413
pubmed: 34905579
Scand J Public Health. 2014 Nov;42(7):554-62
pubmed: 25114064
Can J Occup Ther. 2015 Dec;82(5):283-93
pubmed: 26590228
Int J Audiol. 2003 Jul;42 Suppl 1:S140-2
pubmed: 12918621
Gerontologist. 2005 Jun;45(3):337-46
pubmed: 15933274
Front Psychol. 2020 Sep 25;11:571358
pubmed: 33071905
Am J Med Genet A. 2016 Aug;170(8):2012-21
pubmed: 27273681
Eur J Phys Rehabil Med. 2015 Feb;51(1):105-17
pubmed: 24686893
BMJ Open. 2021 Jan 25;11(1):e044873
pubmed: 33495263
Int J Rehabil Res. 2005 Dec;28(4):309-20
pubmed: 16319556
JBI Evid Synth. 2020 Oct;18(10):2119-2126
pubmed: 33038124
J Aging Health. 2019 Sep;31(8):1353-1375
pubmed: 29896982
PLoS One. 2018 Sep 13;13(9):e0203772
pubmed: 30212504
Trends Amplif. 2007 Dec;11(4):243-58
pubmed: 18003868
PLoS One. 2019 Oct 3;14(10):e0223123
pubmed: 31581243
Curr Rev Musculoskelet Med. 2015 Jun;8(2):134-8
pubmed: 25862485
Arch Phys Med Rehabil. 2019 Dec;100(12):2324-2333
pubmed: 30986411
Health Care Financ Rev. 2003 Spring;24(3):77-88
pubmed: 12894636

Auteurs

Abinethaa Paramasivam (A)

Wittich Vision Impairment Research Lab, School of Optometry, University of Montreal, Montreal, QC, Canada.

Atul Jaiswal (A)

Wittich Vision Impairment Research Lab, School of Optometry, University of Montreal, Montreal, QC, Canada - atul.jaiswal@umontreal.ca.

Shreya Budhiraja (S)

Wittich Vision Impairment Research Lab, School of Optometry, University of Montreal, Montreal, QC, Canada.

Peter Holzhey (P)

Wittich Vision Impairment Research Lab, School of Optometry, University of Montreal, Montreal, QC, Canada.

Praveena Santhakumaran (P)

Wittich Vision Impairment Research Lab, School of Optometry, University of Montreal, Montreal, QC, Canada.

Tosin Ogedengbe (T)

Wittich Vision Impairment Research Lab, School of Optometry, University of Montreal, Montreal, QC, Canada.

Jana Martin (J)

Wittich Vision Impairment Research Lab, School of Optometry, University of Montreal, Montreal, QC, Canada.

Supriya DAS (S)

Wittich Vision Impairment Research Lab, School of Optometry, University of Montreal, Montreal, QC, Canada.

Samuel Côté (S)

Wittich Vision Impairment Research Lab, School of Optometry, University of Montreal, Montreal, QC, Canada.

Romina Hassid (R)

Wittich Vision Impairment Research Lab, School of Optometry, University of Montreal, Montreal, QC, Canada.

Tyler G James (TG)

Department of Family Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.

Beth Kennedy (B)

Central Michigan University, Mt Pleasant, MI, USA.

Diana Tang (D)

Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.

Yvvone Tran (Y)

Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia.

Heather Colson-Osborne (H)

Anne Sullivan Foundation, Stillorgan, Ireland.

Muriel Li Chen Che (M)

CRESAM National Center of Rare Disabilities and Deafblindness, Saint Benoit, France.

Renu Minhas (R)

DeafBlind Ontario Services, Newmarket, ON, Canada.

Sarah Granberg (S)

Örebro University, School of Health Sciences, Örebro, Sweden.

Walter Wittich (W)

Wittich Vision Impairment Research Lab, School of Optometry, University of Montreal, Montreal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH